NCT00723983View on ClinicalTrials.gov

Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Migraine Disorders
Interventions
DRUG

Sumatriptan succinate

Sumatriptan succinate 50 mg taken orally

DRUG

NP101 Study Patch

NP101 study patch 4 hour application

Trial Locations (1)

33009

MD Clinic, Hallandale

Sponsors

Lead Sponsor

NuPathe Inc.
All Listed Sponsors
lead

NuPathe Inc.

INDUSTRY